We and others found that the protein and mRNA expression of AEG-1 is higher in metastatic lesions and in primary tumors from patients with liver or lymph node metastasis compared to the primary tumor from patients without metastasis [23, 26–28]. The gene discussed is MTDH; the disease is metastatic malignant neoplasm in the lymph nodes.